ARCHIVES

NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI

This article is from The Cancer Letter archive.

Vol. 14 No. 04 | January 22, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

NCI Prepares To Dispense A Torrent Of New Money For Cancer Research.

March 6, 2009

Cancer research poised for a “platinum age” as a “golden age” ends, NCI director tells AACR annual meeting.

April 29, 2005

PDQ Evaluation to Cost NCI More Than Reported

June 29, 1990

Some Tumors Show Partial Response To Drug Combo

January 27, 2006

NIH Director Healy Resigned, To Return To Cleveland In June’ Kessler To Remain

March 5, 1993